CA
BIIB icon

Cullinan Associates’s Biogen BIIB Stock Holding History

Cullinan Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,100
Closed -$285K – 242
2023
Q4 		$285K Hold
1,100
– – 0.02% 212
2023
Q3 		$283K Hold
1,100
– – 0.02% 222
2023
Q2 		$313K Hold
1,100
– – 0.02% 220
2023
Q1 		$306K Hold
1,100
– – 0.02% 219
2022
Q4 		$305K Hold
1,100
– – 0.02% 245
2022
Q3 		$294K Hold
1,100
– – 0.02% 206
2022
Q2 		$224K Hold
1,100
– – 0.01% 216
2022
Q1 		$232K Hold
1,100
– – 0.01% 225
2021
Q4 		$264K Sell
1,100
-2,654
-71% -$682K 0.01% 215
2021
Q3 		$1.06M Buy
3,754
+120
+3% +$39.3K 0.06% 143
2021
Q2 		$1.26M Sell
3,634
-12,000
-77% -$3.64M 0.07% 133
2021
Q1 		$4.37M Buy
15,634
+7,420
+90% +$2M 0.25% 96
2020
Q4 		$2.01M Sell
8,214
-13,074
-61% -$3.37M 0.12% 112
2020
Q3 		$6.04M Sell
21,288
-1,389
-6% -$387K 0.39% 69
2020
Q2 		$6.07M Buy
22,677
+6,578
+41% +$1.98M 0.43% 64
2020
Q1 		$5.09M Buy
16,099
+20
+0.1% +$6.07K 0.42% 64
2019
Q4 		$4.77M Sell
16,079
-281
-2% -$78K 0.32% 84
2019
Q3 		$3.81M Buy
16,360
+1,297
+9% +$302K 0.27% 88
2019
Q2 		$3.52M Sell
15,063
-6,257
-29% -$1.44M 0.26% 94
2019
Q1 		$5.04M Buy
21,320
+3,673
+21% +$1.16M 0.38% 73
2018
Q4 		$5.31M Buy
17,647
+5,820
+49% +$1.86M 0.44% 57
2018
Q3 		$4.18M Buy
11,827
+1,479
+14% +$509K 0.3% 89
2018
Q2 		$3M Buy
+10,348
New +$2.91M 0.23% 99
2018
Q1 		– Sell
-650
Closed -$207K – 185
2017
Q4 		$207K Hold
650
– – 0.02% 182
2017
Q3 		$204K Buy
+650
New +$192K 0.02% 189

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cullinan Associates's BIIB Position: Q1 2024 in Review

Cullinan Associates sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,100 shares — an estimated $285K sold.

Cullinan Associates first reported a position in BIIB in Q3 2017 and held it in 25 quarters. The position peaked at $6.07M in Q2 2020. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Cullinan Associates reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Cullinan Associates sold 1,100 Biogen shares in Q1 2024, an estimated $285K.
  • Cullinan Associates first reported a position in Biogen in Q3 2017 and held it in 25 quarters.
  • Cullinan Associates's Biogen position peaked at $6.07M in Q2 2020.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Cullinan Associates's 13F filing for Q1 2024, filed 18 Apr 2024.